Hedgehog signaling in prostate cancer

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Prostate cancer is the most common malignancy and the second leading cancer-related cause of death in men in the USA. Despite enormous efforts in understanding the molecular basis of prostate cancer, very little progress has been made in prevention and treatment of this often lethal cancer. Recent studies have demonstrated that hedgehog signaling is frequently activated in advanced or metastatic prostate cancers. With small molecule inhibitors available to analyze the hedgehog signaling pathway, a novel rationale for prostate cancer therapy can be devised.

Original languageEnglish (US)
Pages (from-to)331-338
Number of pages8
JournalFuture Oncology
Volume1
Issue number3
DOIs
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Second Primary Neoplasms
Cause of Death
Neoplasms
Therapeutics

Keywords

  • basal cell carcinoma
  • cyclopamine
  • patched gene
  • prostate specific antigen
  • small interfering RNA
  • smoothened
  • sonic hedgehog
  • suppressor of fused
  • transurethral resection of the prostate

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hedgehog signaling in prostate cancer. / Xie, Jingwu.

In: Future Oncology, Vol. 1, No. 3, 06.2005, p. 331-338.

Research output: Contribution to journalArticle

Xie, Jingwu. / Hedgehog signaling in prostate cancer. In: Future Oncology. 2005 ; Vol. 1, No. 3. pp. 331-338.
@article{f90445738c2e4fee85f1ff615884a668,
title = "Hedgehog signaling in prostate cancer",
abstract = "Prostate cancer is the most common malignancy and the second leading cancer-related cause of death in men in the USA. Despite enormous efforts in understanding the molecular basis of prostate cancer, very little progress has been made in prevention and treatment of this often lethal cancer. Recent studies have demonstrated that hedgehog signaling is frequently activated in advanced or metastatic prostate cancers. With small molecule inhibitors available to analyze the hedgehog signaling pathway, a novel rationale for prostate cancer therapy can be devised.",
keywords = "basal cell carcinoma, cyclopamine, patched gene, prostate specific antigen, small interfering RNA, smoothened, sonic hedgehog, suppressor of fused, transurethral resection of the prostate",
author = "Jingwu Xie",
year = "2005",
month = "6",
doi = "10.1517/14796694.1.3.331",
language = "English (US)",
volume = "1",
pages = "331--338",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Hedgehog signaling in prostate cancer

AU - Xie, Jingwu

PY - 2005/6

Y1 - 2005/6

N2 - Prostate cancer is the most common malignancy and the second leading cancer-related cause of death in men in the USA. Despite enormous efforts in understanding the molecular basis of prostate cancer, very little progress has been made in prevention and treatment of this often lethal cancer. Recent studies have demonstrated that hedgehog signaling is frequently activated in advanced or metastatic prostate cancers. With small molecule inhibitors available to analyze the hedgehog signaling pathway, a novel rationale for prostate cancer therapy can be devised.

AB - Prostate cancer is the most common malignancy and the second leading cancer-related cause of death in men in the USA. Despite enormous efforts in understanding the molecular basis of prostate cancer, very little progress has been made in prevention and treatment of this often lethal cancer. Recent studies have demonstrated that hedgehog signaling is frequently activated in advanced or metastatic prostate cancers. With small molecule inhibitors available to analyze the hedgehog signaling pathway, a novel rationale for prostate cancer therapy can be devised.

KW - basal cell carcinoma

KW - cyclopamine

KW - patched gene

KW - prostate specific antigen

KW - small interfering RNA

KW - smoothened

KW - sonic hedgehog

KW - suppressor of fused

KW - transurethral resection of the prostate

UR - http://www.scopus.com/inward/record.url?scp=33646453248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646453248&partnerID=8YFLogxK

U2 - 10.1517/14796694.1.3.331

DO - 10.1517/14796694.1.3.331

M3 - Article

C2 - 16556007

AN - SCOPUS:33646453248

VL - 1

SP - 331

EP - 338

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 3

ER -